Open main menu
Providers
Seekers
Plans & Pricing
About Us
BioNeex Interviews
Log In
Sign Up
BioNeex Interviews
Clinical Stage
Interview with CEO of SilkTech Biopharmaceuticals, Brian Lawrence, PhD
Mon Apr 19 2021 22:50:35 GMT+0000 (Coordinated Universal Time)
SilkTech Biopharmaceuticals is Minneapolis based biotech company developing silk-based anti-inflammatory biotherapeutics. Currently, its lead drug candidate, Amlisimod (SDP-4) is in Phase 2 clinical trial for Dry Eye Disease.
Tags and Keywords
Silk-Based Biotherapeutics
Amlisimod (SDP-4)
Phase 2
Dry Eye Disease